Connect with us

Headlines of The Day

Q1FY25: Metropolis Healthcare revenue jumps 13%

Metropolis Healthcare Ltd. reported a 13% revenue growth for the April-June period when compared to the same period last year, the diagnostic services provider said in its quarterly business update.

The growth in Metropolis’ revenue was driven by a 7% growth in patient volumes and a 9.5% year-on-year surge in test volumes. Testing across segments was driven by existing network of centers and partly by new networks.

Metropolis highlighted that it managed to achieve strong revenue growth in the June quarter in West India, which is its largest revenue contributor. This, despite the quarter being a historically soft quarter for the company.

The company further said that Truhealth Wellness and its bundling segment turned out to be the fastest-growing vertical of the company. The healthcare service provider’s B2C revenues surged 18% year-on-year for the June quarter.

Metropolis increased its share in the B2C segments on account of strong brand trust, testing capabilities, and enhanced efforts in curating the wellness portfolio.

The healthcare services provider also said that considering its ongoing investments in new lab expansion, technology enhancement and brand building, the company has been able to increase its margins on a year-on-year basis.

The company added that as of June 30 this year, it is debt free and its cash reserves stood at ₹140 crore.

Shares of Metropolis Healthcare gained as much as 2% post the release of the business update before giving up the gains. The stock is currently flat at ₹2,045.2. CNBCTV18

Copyright © 2024 Medical Buyer

error: Content is protected !!